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Items for this week’s EPI Update include: 
 
 H1N1 quick points for health care providers 
 ALERT: Beware of bogus email for H1N1 vaccination registry 
 Virology Journal report on possible 2009 H1N1 origins 
 Remember to consider testing for enteric illness 
 Meeting announcements and training opportunities 
 
H1N1 quick points for health care providers 
 November 20, 2009 OSHA issued a compliance directive to address flu prevention for 
health care workers whose occupational activities involve contact with patients or 
contaminated material. See www.osha.gov/OshDoc/Directive_pdf/CPL_02_02-075.pdf 
 To date, 644,100 doses of H1N1 influenza vaccine have been shipped to Iowa health 
care providers.  Over the next several weeks it is anticipated that approximately 
100,000 doses of vaccine will be available weekly.  
 As of November 20, 2009, 46 million doses of 2009 H1N1 influenza vaccine have been 
shipped to vaccination providers in the United States.  The H1N1 vaccine safety 
monitoring system, vaccine adverse event reporting system (VAERS), has received 
3,182 reports of adverse events following H1N1 vaccination; 94% of these reports were 
not serious (e.g., encompass things like soreness at the injections site).  The 
percentages of reports for H1N1 influenza vaccine are consistent with what is seen with 
seasonal influenza vaccine.  No new or unusual events or pattern of adverse events 
have emerged from the H1N1 influenza vaccine.  See: 
vaers.hhs.gov/resources/h1n1update#top.   
 CDC has updated its guidance on H1N1 influenza in dental health care settings. See: 
www.cdc.gov/OralHealth/infectioncontrol/factsheets/2009_h1n1.htm 
 Antiviral medications distributed in Iowa 
o Antivirals (Relenza and Tamiflu 75mg capsules) have been released from the 
state stockpile to local public health agencies to be used for patients who meet 
the CDC guidance for antiviral use in treatment or chemoprophylaxis of 2009 
H1N1, and who are underinsured or uninsured. 
o Due to the national shortage of Tamiflu for oral suspension, supplies of oral 
Tamiflu suspension have been distributed for use in patients 2 years of age and 
younger, who meet the CDC guidance for antiviral, regardless of their insurance 
status or ability to pay.  
o Contact your Local Public Health agency for more information.  
o The CDC guidance for antiviral use found at 
www.cdc.gov/H1N1flu/recommendations.htm. 
 
ALERT: Beware of bogus email for H1N1 vaccination registry 
Beware of a bogus e-mail telling Iowans that they must sign up for a state H1N1 flu 
vaccination registry.  The Iowa Department of Public Health and the federal Centers for 
Disease Control and Prevention say the e-mail is bogus.  They said no such registry 
exists, and they warned that people who click on the link could wind up having their 
computers infected with a virus.  
 
Virology Journal report on possible 2009 H1N1 origins 
The Virology Journal published a very interesting article this month speculating on the 
origins of the 2009 H1N1 virus, and cites evidence that the virus had three parents: 1) a 
surface protein similar to 'avian-like' H1N1 isolates from Europe sampled around 1991, 
2) a second protein, also 'avian-like', but identified in Asia around 1999, and 3) a third 
protein similar to the North American 'triple reassortant' virus sampled around 1999.  
The authors propose the virus reassorted once in Mexico at the beginning of 2009.  
 
The existence of 2009 H1N1 highlights the importance of influenza surveillance, 
especially monitoring performed by local-level health care providers. To view the 
abstract on this article, go to www.virologyj.com/content/6/1/207.   
 
Remember to consider testing for enteric illnesses 
Many clinics are continuing to see patients with influenza-like symptoms.  However, if 
you see a patient with symptoms not entirely compatible with influenza and with enteric 
symptoms only or predominately, consider the possibility of enteric illness.  Over the 
past two months, there has been a decrease in the numbers for enteric pathogens 
reported.  Hopefully this is due to many people practicing better hand hygiene. 
However, some instances of true GI illness may be missed.  Please consider testing for 
enteric diseases if you believe your patients may not be ill with influenza. 
 
Meeting announcements and training opportunities  
 
2009 National Laboratory Network Flu Update: Utility of Research Influenza Diagnostic 
Tests (RIDTs) for H1N1 & Seasonal Influenza. Are Rapid Influenza Diagnostic Tests 
(RIDTs) useful in diagnosing influenza A (H1N1) and seasonal influenza?  Audience: 
This intermediate-level program is appropriate for clinicians, laboratory personnel and 
physicians from physician office laboratories and medical clinics.  This program is 
available 24/7.  Register online at www.nltn.org/210-09.htm. 
  
G-290 Public Information Officer (PIO). Dec. 10-11, 8 a.m. to 4 p.m. Atlantic, Iowa.  This 
free 16-hour course will assist participants with building the skills needed to be a full or 
part-time public information officer.  Skills addressed include oral and written 
communications, understanding and working with the media, and the basic tools, latest 
technology and techniques PIOs need.  Register by contacting Lindsay Bollard at 515-
574-1263 or bollard@iowacentral.com   Space is limited, so please register as soon as 
possible. 
  
Biosafety and Biosecurity: Minimizing the Risks in the Laboratory.  On January 13, 
2010, at the University Hygienic Laboratory Ankeny facility, this course will cover the 
differences between biosafety and biosecurity, utilizing biosafety level (BSL) 3 practices 
in a BSL2 lab, and information on conducting risk assessments for both biosafety and 
biosecurity.  For more information contact Rich Bonar at 319-335-4500 or richard-
bonar@uiowa.edu.  
 
Have a healthy and happy week! 
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